ETON PHARMACEUTICALS INC. - COMMON STOCK
14.52
30-July-25 13:45:00
15 minutes delayed
Stocks
+0.09
+0.62%
Today's range
14.25 - 14.89
ISIN
N/A
Source
NASDAQ
-
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
28 Jul 2025 04:00:00 By Nasdaq GlobeNewswire
-
08 Jul 2025 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
27 Jun 2025 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
28 May 2025 14:28:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences
14 May 2025 13:30:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
13 May 2025 13:01:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
01 May 2025 13:30:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
28 Apr 2025 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
01 Apr 2025 04:00:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
18 Mar 2025 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
14 Mar 2025 03:50:00 By Nasdaq GlobeNewswire
-
04 Mar 2025 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules
03 Mar 2025 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
07 Feb 2025 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400
06 Feb 2025 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
03 Jan 2025 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
20 Dec 2024 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
17 Dec 2024 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
03 Dec 2024 03:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
25 Nov 2024 03:50:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >